Acusphere (Imagify)
Allergan (Vistabel)
Alliance (Isprelor)
Alliance (Posidorm)
Astellas (Flomaxtra)
Astellas (Omnic)
Axis-Shield (Afinion)
Bayer (Avelox)
Bayer (Kinzal)
Bayer (Levitra)
BD (Nexiva)
Fresenius Kabi (Applix)
GHX (AllSource)
GSK (Panadol Actifast)
Intercytex (Vavelta)
Merck KGaA
(Formaxx Parteck)

PHTS (Paxiva Zertiva)
Philips (Vequion)
Shire (Fosrenol)
Solvay (Creon)
Tibotec (Prezista)

Intercytex asked Origin to developing a new global brand identity for a ‘facial rejuvenation’ product.

The product works by replacing the missing fibroblasts caused by ageing. Living human (dermal) fibroblasts are used to stimulate soft tissue augmentation, generating collagen and hyaluronic acid to smooth out wrinkles.

Origin generated a wide variety of different name types from which Vavelta was chosen. Easy to pronounce with high-standout, Vavelta communicates the freshness and smoothness of the product through a dynamic, positive and youthful tone.

Download this Case Study